Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07215533 · ClinicalTrials.gov registry record · NA

Effects of HIIT vs. TRE on Type 2 Diabetes Risk

A NA study of Metabolic Diseases and Time-restricted Eating, sponsored by Syracuse University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07215533 is a NA study of Metabolic Diseases and Time-restricted Eating that is actively recruiting participants, run by Syracuse University. The registered enrollment target is 40 participants, below the 195-participant average among 12 other Metabolic Diseases trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07215533, a NA study of Metabolic Diseases and Time-restricted Eating, is actively recruiting participants, sponsored by Syracuse University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this randomized controlled trial is to examine the effects of a 4-week high-intensity interval training (HIIT) and time-restricted eating (TRE) intervention on cardiometabolic biomarkers in adolescents and young adults.

Interventions

  • BEHAVIORAL Time-restricted eating
  • BEHAVIORAL High-intensity interval training

Study Locations (1)

New York

  • Syracuse University - Syracuse

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-03-15
Est. Completion 2025-12-30
Phase NA

Sponsor

Syracuse University

31 total trials

What the Registry Record Tells You About NCT07215533

The ClinicalTrials.gov registry entry for NCT07215533 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 195-participant average among 12 other Metabolic Diseases trials with a reported enrollment target (79% lower). The listed sponsor is Syracuse University, which has 31 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Metabolic Diseases appearing as the primary indexed condition, and to 2 interventions - of which Time-restricted eating is the first listed.

NCT07215533 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07215533 about?

NCT07215533 is a clinical study titled "Effects of HIIT vs. TRE on Type 2 Diabetes Risk". The primary aim of this randomized controlled trial is to examine the effects of a 4-week high-intensity interval training (HIIT) and time-restricted eating (TRE) intervention on cardiometabolic biomarkers in adolescents and young adults.

What is the current status of trial NCT07215533?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-03-15. Estimated completion is 2025-12-30.

What conditions does trial NCT07215533 study?

This clinical trial studies the following conditions: Metabolic Diseases, Time-restricted Eating, Obesity and Type 2 Diabetes, High Intensity Interval Training.

What interventions are being tested in trial NCT07215533?

The interventions under investigation include: Time-restricted eating (BEHAVIORAL), High-intensity interval training (BEHAVIORAL).

Who is sponsoring clinical trial NCT07215533?

This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07215533 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Metabolic Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.